 |
|
|
| |
12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial
|
| |
| |
Reported by Jules Levin
Durban 2016 IAS July 18-22
Cissy Kityo, Abraham Siika, Alexander J. Szubert, Jane Mallewa, Mutsa
Bwakura-Dangarembizi, Sheila Kabahenda, Shalton Mwaringa, Sarah L. Pett, Anna Griffiths, Abbas Lugemwa, Simon Wachira, Godfrey Musoro, Chatu Rajapakse, Timothy Etyang, James Abach, Priscilla Wavamunno, Linda Nyondo-Mipando, Andrew Reid, Kusum Nathoo, James Hakim, Diana M. Gibb, A. Sarah Walker
and the REALITY trial team
|
| |
|
|
|
|
|
